As we step into January 2025, global markets are witnessing a mixed sentiment with U.S. consumer confidence on the decline and key indices such as the Nasdaq Composite showing moderate gains amidst a backdrop of fluctuating economic indicators. In this environment, identifying high-growth tech stocks that can navigate these uncertainties requires a keen focus on innovation and adaptability to shifting market dynamics.

Click here to see the full list of 1262 stocks from our High Growth Tech and AI Stocks screener.

Here's a peek at a few of the choices from the screener.

Simply Wall St Growth Rating: ★★★★★★

Overview: Bonesupport Holding AB (publ) is an orthobiologics company that develops and commercializes injectable bio-ceramic bone graft substitutes across Europe, North America, and other international markets, with a market cap of SEK25.45 billion.

Operations: Bonesupport generates revenue primarily from its pharmaceuticals segment, with SEK814.46 million attributed to this area. The company focuses on developing and commercializing injectable bio-ceramic bone graft substitutes across various regions.

BONESUPPORT Holding, amid a challenging backdrop with a 57.6% dip in earnings last year, still forecasts robust future growth with expected revenue and earnings increases of 33.5% and 72.2% per annum, respectively. This optimism is underpinned by strategic R&D investments which have consistently constituted a significant portion of their budget, reflecting their commitment to innovation in biotechnology solutions for bone healing. Recent developments include the SOLARIO study outcomes which demonstrated the efficacy of BONESUPPORT's products in reducing systemic antibiotic use -- a key advancement in surgical treatments that could reshape clinical practices globally. Furthermore, the recent executive changes and stake acquisitions signal potential strategic shifts that might influence future operations and market positioning.